Your browser doesn't support javascript.
loading
SLIT mutations as potential predictive biomarkers for immunotherapy in NSCLC.
Zhou, Tong; Yi, Huan; Zhu, Chan; Yu, Yangyang; He, Qianru; Xiao, Mingzhe; Qi, Chuang; Lu, Tianyu.
Afiliação
  • Zhou T; Medical Oncology Department, The Fourth People's Hospital of Changzhou, Changzhou, China.
  • Yi H; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • Zhu C; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • Yu Y; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • He Q; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • Xiao M; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • Qi C; The State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co, No.699-18 Xuanwu Avenue, Nanjing, China.
  • Lu T; Thoracic Surgery Department, The first hospital of Jilin University, No.71 Xinmin Street, Changchun, China. luty17@mails.jlu.edu.cn.
Invest New Drugs ; 41(2): 251-253, 2023 04.
Article em En | MEDLINE | ID: mdl-37036581
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China